ArticleKidney international reports2024

Systematic Review of Cardiovascular Benefits and Safety of Sacubitril-Valsartan in End-Stage Kidney Disease.

Mariam Charkviani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.